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Results: Fifty-six patients (31.6%) had elevated cTnl > 1.0 ng/mL at the time of PE diag- 
nosis. Patients with elevated cTnl were older (p<0.01) and had higher incidence of malig- 
nancy (p=0.06) but no increased prevalence of prior MI or CAD (p=0.62). Elevated cTnl 
was assoicated with adverse outcomes including 30-d mortality (p<0.01) (Table 1). After 
adjusting for possible confounders, the association of cTnl with adverse outcomes 
remained. 
Conclusions: In the setting of acute PE, elevated cTnl is associated with increased 30-d 
mortality and adverse cardiopulmonary/ hemodynamic outcomes. Elevated cTnl may 
identify high risk patients with PE more likely to benefit from aggressive therapies such 
as thrombolysis. 
Troponin I < 1.1 ng/ Troponin I > 1.0 Adjusted RR P 
mL (n=121) ng/mL (n=56) (95% CI) value 
Peak cTnl 0.3 ± 0.3 6.3 ± 12.4 <0.001 
Age (years) 65.7 ± 16.3 71.9 ± 14.0 <0.01 
Prior MI/Known CAD 25% 21% 0.63 
30-day Mortality 12% 34% 2.2 (1.5,3.3) <0.001 
Hemodynamcic 13% 61% 4.5 (2.7,7.3) <0.001 
Compromise 
Mechanical 17% 48% 2.6 (1.7,4.1) <0.001 
Ventilation 
Pressor Support 9% 36% 2.9 (1.8,4.6) <0.001 
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1033-90 The Angiotensin II Type I Receptor Associated Protein 
ATRAP Is a Transmembrane Protein and Negative 
Modulator of Angiotensin II Signaling 
Marco A. Looez-Ilasaca. Victor J. Dzau, Brigham & Women's Hosp., Boston, 
Massachusetts, Harvard Medica/ School, Boston, Massachusetts. 
AT1 receptor-associated protein (ATRAP) was identified by our group in a yeast two- 
hybrid screen for proteins that bound to the carboxyl-terminal cytoplasmic domain of the 
Angiotensin II type 1 receptor (AT1). In this work we characterize ATRAP as a transmem- 
brane protein, localized in the endoplasmic reticulum and plasma membrane that func- 
tions as a negative modulator of Angiotensin II-induced signal transduction. Endogenous 
and transfected ATRAP cDNA shows a particulate distribution; hydrophobicity analysis of 
the primary structure of ATRAP reveals the presence of three transmembrane domains 
at the amino terminal of the protein and a hydrophilic cytoplasmic carboxyl-terminal tail 
Over-expression of ATRAP mutants show that the deletion of the C-terminal domain of 
ATRAP leads to the formation of prominent perinuctear vesicle clusters, whereas the 
deletion of the N-terminal transmembrane domains leads to a diffuse cytoplasmic distri- 
bution of the protein. Electron microscopy reveals the presence of ATRAP in prominent 
perinuclear vesicular membranes; colocalization analysis by immunofluorescence show 
that ATRAP colocalize in the same vesicular compartment of the endoplasmic reticulum 
marker DiOC6(3). Real time following of ATRAP vesicles shows constitutive translocation 
towards the plasma membrane. Using epitope tagged forms of ATRAP either at the 
amino or carboxyl ends of the molecule, we determined the orientation of the amino end 
as being outside the cell. Functional analysis of the effects of ATRAP on Ang-tl induced 
AT1 receptor signaling reveals a moderate decrease in the generation of inositol lipide, a 
marked decrease of the Ang II-stimulated transcriptional activity of the c-foe promoter 
luciferase reporter gene, and decrease in cell proliferation. These results implicate 
ATRAP as a modulator of AT1 receptor signaling acting in a vesicular compartment, via 
interactions with the C-terminal domain of the receptor. 
1033-91 Mechanisms of Thromboxane A 2 Associated Apoptosis 
in Adult Cardiac Myocytes: Role of Protein Kinase C 
Zeta Mediated Downregulation of Akt Activity 
Yukitaka Shizukuda, Jayant Bagai, Mary E. Reyland, Peter M. Buttdck, University of 
Illinois at Chicago, Chicago,///inois, University of Colorado, Denver, Colorado. 
Background: Apoptosis (Apo) is seen in myocardium exposed to acute ischemic insults 
and Apo may be in part mediated by increased thremboxane A2 (TXA) level. We investi- 
gated the role of protein kinase C (PKC) in Apo induced by TXA. Methods: Adult rat ven- 
tricular myocytes (ARVM) were cultured for 48 h before pharmacological interventions. 
The involvement of PKC was measured with both translocation and immune complex 
kinase assay. Akt activity was measured with both immunoblotting and immune complex 
kinase assay, The extent of apoptosis was assessed with TUNEL and DNA ladder assay. 
Results: Treatment with a TXA mimetic, IBOP for 24 h induced Apo in ARVM in a dose- 
dependent fashion (35.0±3.0% in 100 nM IBOP vs. 13.9±1.6% in controls, P<0.05, data 
expressed as %TUNEL positive cells). The Apo by TXA was completely inhibited by a 
TXA receptor specific inhibitor SQ29548. TXA stimulation resulted in membrane translo- 
cation of PKC~ at 3 min and 1 h stimulation, but not PKC~, LSII, 5, and E. The isoenzyme 
specific activation of PKC~ was confirmed by an immune complex kinase assay. The 
activation of PKC~ by TXA was also associated with reduction of Akt activity. A cell per- 
meable PKC~ specific pseudosubstrate peptide (~PS; a gift from Dr. Mochly-Rosen, 
Stanford University, CA) inhibited apoptosis by TXA at a dose which inhibited TXA-medi- 
ated increase in PKC£~ activity (1 ~M). ~PS also prevented Akt reduction by TXA. The 
anti-apoptotic effect of ~PS was completely abolished by phosphatidylinositol 3-kinase 
inhibitors which inhibit ~PS mediated preservation of Akt activity. In addition, moderate 
PKC~ overexpression for 36 h by adenovirus vector (4.5-fold control) reduced Akt activity 
to half as well as exaggerated apoptosis by TXA (40.8±3.5% with 100 nM IBOP, P<O.05 
vs. 100 nM IBOP alone). 
Conclusion: The activation of PKC~ by thromboxane A2 suppresses Akt activity which in 
turn, promotes apoptosis in adult cardiac myocytes. Therefore, PKC~ specific inhibition 
and/or activation of Akt might be useful in preventing thromboxane A2 mediated cardiac 
injury. 
1033-92 St imulat ion  of  Cyc l ic  AMP Synthesis by Combined 
Overexpression of the Nucleoside Diphosphate Kinase 
NM23H2 and the Alpha-Subunit of Gs Proteins 
Feravdoon Niroomand. Hans-Joerg Hippe, Susanne Lutz, Katrin Knorr, Matthias 
Meyborg, University of Heidelberg, Heidelberg, Germany. 
Background: G proteins are mediators of signalling pathways that are implicated in the 
development of cardiac hypedrophy and dilation. We have recently suggested a recep- 
tor-independent mechanism of G protein activation by a membrane-associated nucleo- 
side diphosphate kinase (NDPK). In saroolemmal membranes from failing human hearts, 
the level and activity of NDPK were elevated three-fold, leading to a 50- to 75% inhibition 
of cAMP-synthesis. This finding could reflect activation of the likewise increased Gi pro- 
teins. To prove the interaction of NDPK with a G protein, we transfected cells with genes 
encoding for NDPK and the atpha-subunit of the stimulatory G protein Gsalpha. Methods: 
Immortalized cells, derived from neonatal rat hearts, were stably transfected with the 
NDPK-gene NM23-H2. Overexpression of Gsalpha was induced with a recombinant ade- 
novirus. Intracellular cAMP and adenylyl cyclase activity (AC), NDPK-activity, Gsalpha 
and Gialpha in membranes were determined. Results: Overexpression of Gsalpha led to 
an increase in cAMP synthesis in all cell clones, despite the presence of the inverse ago- 
nist propranolol. This increase was strictly proportional to the level of NDPK activity in 
seven different clones. In cells with a 2.7-fold overexpression of NDPK and a 10-fold 
overexpression of Gsalpha, intracellular cAMP was increased 200-fold compared to con- 
trol cells. Stable transfection of the cells with a catalytically inactive NDPK did not 
increase cAMP-synthesis. Intracellular nucleotide concentrations were not influenced by 
the overexpression of NDPK. In crude membranes from these cells, basal, G protein 
independent AC activity was similar in all clones. However in cells overexpressing Gsal- 
pha and NDPK, activity in the presence of GDP was increased proportionally to the level 
of NDPK activity. In conclusion, these results demonstrate for the first time a functional 
interaction of NDPK with a G protein in an intact cell. 
1033-93 Antioxidant Vitamins C and E Administration in 
Smokers: Effects on Endothelial Function and Serum 
Levels of Soluble Intercellular Adhesion Molecule-I, 
Soluble Vascular Cell Adhesion Molecule, and Lipid 
Hydroperoxides 
Dimitris Tousoulis, Charalambos Antoniades, Marina Toutouza, Costas Tentolouris, 
Kyriakoula Marinou, George Goumas, Athanasios Tdkas, Costas Toutouzas, 
Christodoulos Stefanadis, Pavlos Toutouzas, Cardiology Unit Hippokration Hospital, 
Athens University Medical School, Athens, Greece. 
Background: Serum levels of soluble vascular cell adhesion molecule (sVCAM-1) and 
soluble intercellular adhesion molecule (slCAM-1), as well as lipid hydroperoxides (LPO) 
(marker of lipid peroxidation), are implicated in the pathogenesis of atherosclerosis. Pur- 
pose of this study is to investigate the effect of combined administration of antioxidant 
vitamins C and E on endothelial function, and serum levels of slCAM-1, sVCAM-1 and 
LPO, in chronic smokers. 
Methods: 36 healthy young smokers (20 males 16 females aged 36±2 years) were 
enrolled in this double blind placebo controlled study. Subjects were divided into 4 groups 
receiving vitamin C 2g/day (n=10) (group A), vitamin C 2g/day and vitamin E 4001U/day 
(n=11) (group B), vitamin C 2g/day and vitamin E 8001U/day (n=9) (group C) or placebo 
(n=6) (group D), for 4 weeks. Forearm blood flow was measured using venous occlusion 
strain gauge plethysmography. Endothelium dependent ftow mediated vasodilation 
(FMD) was expressed as the % change from baseline to post reactive hyperemia blood 
flow. Endothelium independent % change flow (NTR%) was assessed after sublingual 
nitroglycerin administration. Plasma levels of sVCAM1, and slCAM1 were determined by 
enzyme linked immunosorbent assay, while LPO was determined using a spectrephoto* 
metric assay. 
Results: Blood pressure, heart rate, body weight, basal forearm blood flow and NTR% 
were similar before and after treatment. FMD was significantly increased in groups B 
(46.6±5.5 to 74.1±9.3%, p<0.05) and C (43.6±3.9 to 74.9±4.2%, p<0.01), while remained 
unaffected in groups A and D. Serum levels of sVCAM-1 and slCAM-1 significantly 
reduced in group C (from 339±14 and 318±21 to 298±11 and 250±19 ng/ml respectively, 
p<O.O5 for both), while remained unaffected in groups A, B and D. LPO was significantly 
reduced in groups B and C (from 14.5±1.2 and 15.4±2.9 to 8.8±1.6 and 8.3±1.7 I~M 
respectively, p<0.05 for both). 
Conclusions: Chronic administration of vitamin C (2g/day) combined with vitamin E 
(8001U/day), reduces blood levels of sVCAM-1 and slCAM-1, improves endothelial func- 
tion and reduces lipid peroxidation in healthy young smokers. These findings may have 
therapeutic implications in chronic smokers 
